The correct Marketing Authorization application for a medicinal product, together with product particularities and complex regulatory requirements are key steps to be considered to ensure timely product commercialization in strategically defined markets.


Following evidence generation that indicates a product has the successful adequacy to treat a medical need, an appropriate regulatory registration procedure is required prior to commercialization.

This entails the definition, execution and formatting of registration eCTD dossiers and their management in terms of timing and content presentation, which are usually subject to standard formats and procedures requested by multiple authority bodies in each regulatory framework. This involves also a contextualization of such procedures regarding the type of product and the medical need to be covered.

Asphalion’s expertise aims at ensuring timely commercialization given the complexity of multiregional contexts, which requires a proper planning and management of document submission and product registration.

Registration Solutions

  • Support and Management of new marketing authorization submissions to comply with critical timelines
  • Assessment of regional requirements
  • Centralized Procedures (CP) in EMA
  • Decentralized Procedures (DCP) with all European Agencies and National Phases (NP)
  • FDA projects (IND, NDA, BLA, ANDA)
  • Local support in UK registrations using the new national portal.
  • Management of Spanish authorities’ portals and databases (e.g., RAEFAR)
  • Marketing Authorization transfers
  • Reliable coordination of local partners for global registration procedures (ROW)
  • Translations management for regulatory submissions processes. More specifically, in EU Centralized Procedures we manage translations from pre-opinion up to linguistic review and opinion by agencies
  • Module 1 for new MAA.
  • Elaboration of pre-clinical sections (Module 2.4 and 2.6)
  • Elaboration of clinical sections (Module 2.5 and 2.7)
  • Elaboration of CMC sections (Module 3)
  • Expert’s signature
  • Gap analysis and update of CMC: non-clinical and clinical sections
  • Technical documentation: scientific reports
  • Readability tests for all types of EU registration procedures
  • Transparency compliance (Policy 0070): documentation masking, anonymization reports
  • Adequate registration for regional authorities: AEMPS, EMA, UK and FDA
  • Due Diligence of in-licensing dossiers
  • Expert support on responses to Deficiency Letters
  • Comprehensive eCTD services
  • eCTD compilation and publishing
  • Full life cycle support for Europe, USA, Canada, Switzerland, Saudi Arabia, GCC, and more
  • Information management (RIMS solution)
  • Software installation, training, validation and support
  • Data consolidation for evidence presentation in submissions
  • Adequation and data retrieval and management to ISO IDMP standards
  • Tool review and selection (RFP, RFI)
  • Tool and process adaptation and implementation
  • Data mapping with SPOR master data
  • Gap analysis of IDMP readiness
  • Conformity assessment for medical devices: Medical device EU Certification Procedure assistance
  • Country-specific medical device regulatory support
  • Product registration
  • Assistance with local Competent Authorities communication and other local requirements
  • General safety and performance requirements
  • Risk analysis
  • Clinical Evaluation Reports (CERs)
  • Instructions for use and labelling

Schedule a free meeting!

Discuss your case with our experts and receive a valuable feedback


Why Asphalion?

Asphalion has a focused expertise in complying with challenging regulatory requirements, highly tailored for a wide diversity of regional contexts in which multiple agents intervene and allows Asphalion to be a leading partner on the execution, presentation and follow-up of technical regulatory documents, which allows contextualized product registration and maximized efficiency.

At Asphalion we know the requirements that documents must meet in order to be timely approved, especially in dossiers for registration procedures, such as CTD, technical documents for scientific reports or transparency compliance reports.

We cover all aspects, starting from scientific and medical writing, up to support of the registration procedure in compliance with the regulations of each country.

Related Resources

Access consortium

Access Consortium

The Access consortium is a medium-sized coalition of regulatory authorities from Australia, Canada, Singapore, Switzerland and the UK that work together to promote greater regulatory collaboration and alignment of regulatory requirements.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Related News & Events

EVENT | Symposium AEFI 2024

¡Mañana arranca el 42º Symposium de AEFI! No olvidéis visitarnos en la mesa 6 para conocer de todos los servicios que ofrecemos. Os recordamos los talleres que impartirán nuestros expertos

EVENT | RAPS Euroconvergence

Dates: May 6-8 | Berlin Congress Centre Day 1 at RAPS! ASPHALION’s team is in Berlin!! Come by booth B2 to get to know us and see the array of

EVENT | 20th Biosimilar Medicines Conference by MFE

During these two interactive days, actors of the healthcare community alongside world experts in biosimilar medicines will gather and debate the evolving biosimilar medicines landscape and emerging trends. Discussion will focus on sharing good practices and setting collective aims to achieve the depth, breadth and speed of the use of biosimilar medicines as a lever to untap their transformative value.

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting